piperocaine monohydrochloride
Small moleculeexperimental
Piperocaine (Metycaine) is a local anesthetic drug. It is an ester and primarily is a sodium channel blocker. Piperocaine can partially inhibit dopamine. It is known as a alpha-1-proteinase inhibitor. Used in the form of its hydrochloride as a local or spinal anesthetic and in dental anesthesia. Can cause toxic reactions. Piperocaine Hydrochloride is in the list of Bulk Drug Substances Nominated for Use in Compounding Under Section 503A, FDA Act. Piperocaine hydrochloride is a small, white odorless crystals or a white crystalline powder, stable in air, freely soluble in water, alcohol and chloroform. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Indications
Approved for
Chemistry & pharmacology
Loading structure…
SMILES
CC1CCCCN1CCCOC(=O)C2=CC=CC=C2- Mol. weight
- 261.3593 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSF66XUI6GZL ↗
- ChEMBLCHEMBL127865 ↗
Also known as
- (+/-)-2-methyl-1-piperidinepropanol benzoate (ester)
- 2-methylpiperidinepropanol benzoate
- neothesin
- piperocaine
- piperocaine hydrochloride
- piperocaine hydrochloride
- piperocaine hydrochloride
- piperocaine, (+-)-isomer
- piperocaine monohydrochloride
- piperocaine monohydrochloride, (+-)-isomer